Trial Profile
Influenza Therapeutic Trial: A Pilot Randomized Controlled Trial for Feasibility of Enrolling Subjects for Influenza Therapeutic Trials and Administering Influenza Antivirals in the Emergency Department to High Risk Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 20 Sep 2019 Status changed from active, no longer recruiting to completed.
- 30 Oct 2018 Planned End Date changed from 31 Jul 2018 to 21 Aug 2019.
- 22 May 2018 Planned End Date changed from 1 Sep 2018 to 31 Jul 2018.